Bormioli Pharma continues its investments to support the growing demand for packaging solutions for both vaccines and, more generally, for the various therapeutic treatments used to fight Covid-19 infections.
The Vasto plant, specialised in the production of rubber stoppers and aluminium seals for containers used for injectable drugs, is one of the industrial sites where the Group plans to undertake significant works to increase production capacity. The current maximum capacity, which amounts to around 100 million closures per year, will soon reach 150 million and will further increase to 200 million in just a few months.
In this news report – click here to watch the video – broadcast on Rai 3’s Abruzzo regional news, Site Manager, Ezio Scifo, comments on recent investments and some of the important collaborations already underway for vaccine packaging.
10.03.2021, Bormioli Pharma
News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.